ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection

Abroad (travel likely)RecruitingPHASE4

Conditions

Chronic Hepatitis b

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The 2nd affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China
Contact: Study coordinator (HONG REN) · renhong0531@vip.sina.com · +8613983888786
Contact: Study coordinator (Dachuan Cai) · cqmucdc@cqmu.edu.cn · +8618323409779
Contact: Principal Investigator (HONG REN)

Study leads

Hong Ren, MM
Study Director
The Second Affiliated Hospital of Chongqing Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B

Hepatitis B · Viral Hepatitis

Abroad (travel likely)RecruitingPHASE4

Taichung, Taiwan

SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus

Chronic Hepatitis B

Abroad (travel likely)RecruitingPHASE4

Hong Kong, Hong Kong

A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs

Chronic Hepatitis B

Abroad (travel likely)RecruitingPHASE2

Beijing, China

Evaluation of Patients With Liver Disease

Hepatitis D · Hepatitis C · Hepatitis B

Abroad (travel likely)Recruiting

Bethesda, United States